Time between attacks · people with colchicine‐resistant familial Mediterranean fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Prevention of AA amyloidosis · people with colchicine‐resistant familial Mediterranean fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse drug reactions · people with colchicine‐resistant familial Mediterranean fever
1 finding from 1 review
Time between attacks · people with familial Mediterranean fever
1 finding from 1 review
Acute‐phase response · people with colchicine‐resistant familial Mediterranean fever
1 finding from 1 review
Number of participants experiencing an attacka · children with familial Mediterranean fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of attacksa · children with familial Mediterranean fever
1 finding from 1 review
Time between attacks · children with familial Mediterranean fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Prevention of AA amyloidosis · children with familial Mediterranean fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse drug reactions · children with familial Mediterranean fever
1 finding from 1 review
Acute‐phase response · children with familial Mediterranean fever
1 finding from 1 review
Prevention of AA amyloidosis · people with familial Mediterranean fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse drug reactions · people with familial Mediterranean fever
It is very uncertain whether colchicine (oral) changes adverse drug reactions compared with placebo (very low certainty).
1 finding from 1 review
Acute‐phase response · people with familial Mediterranean fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of participants experiencing an attacka · people with familial Mediterranean fever
Rilonacept showed no clear difference in number of participants experiencing an attacka compared with placebo (moderate certainty).
1 finding from 1 review
Duration of attacksa · people with familial Mediterranean fever
1 finding from 1 review
Time between attacks · people with familial Mediterranean fever
1 finding from 1 review
Fetal immobilisation score at 40 minutes (Degree of fetal immobilisation as defined by trial authors) · health problem or population
1 finding from 1 review
Fetal movements ‐ gross body and limb (Degree of fetal immobilisation as defined by trial authors) · health problem or population
1 finding from 1 review
Surgical assessment/satisfaction score = 1 or 2 (Technically successful procedure as defined by trial authors) · health problem or population
Summary of findings table ‐ Remifentanil may leads to higher surgical assessment/satisfaction score = 1 or 2 (Technically… compared with diazepam (low certainty).
1 finding from 1 review